Polymorphism, Structure, and Nucleation of Cholesterol·H 2 O at Aqueous Interfaces and in Pathological Media: Revisited from a Computational Perspective.
Margarita ShepelenkoAnna HirschNeta VarsanoFabio BeghiBenjamin A PalmerLeeor KronikLeslie LeiserowitzPublished in: Journal of the American Chemical Society (2022)
We revisit the important issues of polymorphism, structure, and nucleation of cholesterol·H 2 O using first-principles calculations based on dispersion-augmented density functional theory. For the lesser known monoclinic polymorph, we obtain a fully extended H-bonded network in a structure akin to that of hexagonal ice. We show that the energy of the monoclinic and triclinic polymorphs is similar, strongly suggesting that kinetic and environmental effects play a significant role in determining polymorph nucleation. Furthermore, we find evidence in support of various O-H···O bonding motifs in both polymorphs that may result in hydroxyl disorder. We have been able to explain, via computation, why a single cholesterol bilayer in hydrated membranes always crystallizes in the monoclinic polymorph. We rationalize what we believe is a single-crystal to single-crystal transformation of the monoclinic form on increased interlayer growth beyond that of a single cholesterol bilayer, interleaved by a water bilayer. We show that the ice-like structure is also relevant to the related cholestanol·2H 2 O and stigmasterol·H 2 O crystals. The structure of stigmasterol hydrate both as a trilayer film at the air-water interface and as a macroscopic crystal further assists us in understanding the polymorphic and thermal behavior of cholesterol·H 2 O. Finally, we posit a possible role for one of the sterol esters in the crystallization of cholesterol·H 2 O in pathological environments, based on a composite of a crystalline bilayer of cholesteryl palmitate bound epitaxially as a nucleating agent to the monoclinic cholesterol·H 2 O form.